Evidence map›Paper›PMID 35395756›Full record

ArticleBMC cancer2022

The circular RNA circFARSA sponges microRNA-330-5p in tumor cells with bladder cancer phenotype.

Chen Fang, Xin Huang, Jun Dai, Wei He, Le Xu, Fukang Sun

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Bladder cancer: non-coding RNAs and exosomal non-coding RNAs.Functional & integrative genomics · 2024
    Review
  3. Article
  4. Article
  5. The Tumorigenic Role of Circular RNA-MicroRNA Axis in Cancer.International journal of molecular sciences · 2023
    Review
  6. Integration of TE Induces Cancer Specific Alternative Splicing Events.International journal of molecular sciences · 2022
    Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chen Fang *Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijing 2nd Road, Shanghai, 200025, China.
Xin Huang *Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijing 2nd Road, Shanghai, 200025, China.
Jun DaiDepartment of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijing 2nd Road, Shanghai, 200025, China.
Wei HeDepartment of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijing 2nd Road, Shanghai, 200025, China.
Le XuDepartment of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijing 2nd Road, Shanghai, 200025, China.
Fukang SunDepartment of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijing 2nd Road, Shanghai, 200025, China. sfkang66@163.com.
Shanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCircular RNAs (circRNAs) modulate gene expression in various malignancies. However, their roles in the occurrence of bladder cancer (BC) and their underlying mechanisms of action are currently unclear.

methodsWe measured levels of the circRNA phenylalanyl-tRNA synthetase subunit alpha (circFARSA) and target microRNAs (miRNAs/miRs) in BC tissues and cell lines using quantitative polymerase chain reactions. The functions of circFARSA in tumor formation were examined in mice with BC xenografts in vivo and in BC cells via determination of their proliferation, activity, apoptosis, metastasis, and invasion in vitro using cell counting kit-8 assays, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, flow cytometry, western blotting, Transwell assays, and cell wound healing assays. Interactions between miR-330 and circFARSA were predicted and confirmed by bioinformatic processing and dual-luciferase reporter gene assays, respectively. Expression profiles of miR-330 targets in BC cells were assessed via western blotting.

resultscircFARSA expression was markedly upregulated in BC tissues and cell lines compared with that in normal bladder samples. Silencing circFARSA expression decreased BC cell proliferation, invasion, and migration but induced their apoptosis in vitro. Downregulating circFARSA expression slowed tumor growth in vivo and directly sponged miR-330 and inhibited its function in BC cells in vitro. Inhibiting miR-330 expression abolished the regulatory effects of circFARSA silencing on the tumor phenotypes of BC cells.

conclusionscircFARSA expression is upregulated and exerts oncogenic functions in BC by sponging miR-330.

Indexed as

MicroRNAsRNA, CircularUrinary Bladder NeoplasmsAnimalsApoptosisCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansMicePhenotypeMicroRNAsMIRN330 microRNA, humanRNA, CircularBladder cancercircFARSAInvasionmiR-330ProliferationTumor phenotype

Identifiers

PMID35395756
PMCPMC8991568
OpenAlexW4223455752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.